Debt - Additional Information (Details) - USD ($)					1 Months Ended		2 Months Ended	3 Months Ended		6 Months Ended		10 Months Ended
	Apr. 01, 2023	May 09, 2022	Dec. 31, 2021	Mar. 19, 2021	Feb. 28, 2023	Apr. 30, 2022	Jun. 30, 2022	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Jan. 31, 2023	Aug. 31, 2021
Debt Instrument [Line Items]
Cash and cash equivalents			$ 32,712,000				$ 23,586,000	$ 23,586,000		$ 23,586,000
Common stock, par value			$ 0.001				$ 0.001	$ 0.001		$ 0.001
Description of securities purchase agreement										(i) purchased a secured promissory note (Promissory Note One) in the aggregate principal amount totaling $16.0 million in exchange for $15.0 million less certain expenses and (ii) agreed to purchase another secured promissory note at the Company’s election (Promissory Note Two and, together with Promissory Note One, the Promissory Notes), subject to certain conditions precedent in aggregate principal amount totaling $10.3 million in exchange for $10.0 million in cash proceeds.
Maximum purchase percentage of investors on future equity and debt securities offerings		$ 30,000
Number of shares reserved for issuance							195,426	195,426		195,426			338,106
Promissory notes interest rate		6.00%
Promissory note, maturity term		24 months
Promissory notes early prepayment premium percentage		10.00%
Promissory note, redemption description										The Redemption Conversion Price shall equal 85% multiplied by the lowest daily VWAP during the ten trading days immediately preceding the date the Lender delivers notice electing to redeem a portion of the Promissory Note. The Company’s right to satisfy the redemption amount in shares of Common Stock is subject to certain limitations, including (i) there not being any Equity Conditions Failure (as defined in the Note), (ii) the Lender and its affiliates together not owning more than 9.99% of the outstanding shares of Common Stock, and (iii) the aggregate shares of Common Stock issued upon redemption of the Promissory Notes not exceeding 19.99% of the outstanding Common Stock unless the Company has obtained stockholder approval under NASDAQ rules for such issuance.
OID and debt issuance costs			$ 63,000				$ 2,950,000	$ 2,950,000		$ 2,950,000
Interest expense							100,000	1,346,000	$ 815,000	2,483,000	$ 1,466,000
Accrued interest							100,000	100,000		100,000
Loss on debt extinguishment						$ (18,000)		(2,952,000)		(2,952,000)	$ (728,000)
2021 Term Loan Partial Repayment in April 2022
Debt Instrument [Line Items]
Repayments of debt						3,000,000.0
Principal Repayment
Debt Instrument [Line Items]
Repayments of debt						2,000,000.0
Securities Purchase Agreement
Debt Instrument [Line Items]
Number of shares reserved for issuance		37,000,000.0
Integrated Diagnostics Asset Purchase Agreement
Debt Instrument [Line Items]
Milestone payment						2,000,000.0
Promissory Note One
Debt Instrument [Line Items]
Notes/Loan payable							16,164,000	16,164,000		$ 16,164,000
Promissory Note One | Securities Purchase Agreement
Debt Instrument [Line Items]
Debt instrument, aggregate principal amount		$ 16,000,000.0
Proceeds from Notes Payable		15,000,000.0
Proceeds from net of debt issuance costs and original issue discounts		12,800,000
Description on debt instrument conditions										(i) within nine months following the First Closing Date, repayment in full all outstanding obligations under the 2021 Term Loan, (ii) the Company shall have received no less than $5.6 million in proceeds from the sale (not attributable to Lender or its affiliates) of newly issued equity securities during the period beginning on the First Closing Date and ending on January 31, 2023 (the Second Closing Date), (iii) on or before the Second Closing Date, the Company shall have met or exceeded Revenue Milestone 1 (as defined in the Promissory Notes), (iv) (a) the aggregate market value of the Company’s common stock and any other equity securities held by persons that are not affiliates of the Company on the Second Closing Date shall be greater than or equal to $75.0 million or (b) received no less than $20.0 million in additional proceeds from the sale (not attributable to Lender or its affiliates) of new equity securities in the Company not counting those proceeds set forth in item (ii) above (for total proceeds of no less than $25.6 million during the period beginning on the First Closing Date and ending on the Second Closing Date; (v) as of the Second Closing Date, Company is in good standing with Nasdaq Stock Market (the NASDAQ) and has not received any notice of non-compliance; (vi) Company shall be current in its payments to Indi, and (vii) there being no Trigger Event (as defined in the Promissory Notes) under Promissory Note One. If Promissory Note Two is issued, the terms of Promissory Note One and Note Two will be substantively identical.
Original issue discounts on debt instrument issuance		1,000,000.0
OID and debt issuance costs		3,200,000
Amortization of OID and debt issuance costs							300,000
Promissory Note Two | Securities Purchase Agreement
Debt Instrument [Line Items]
Debt instrument, aggregate principal amount		10,300,000
Proceeds from Notes Payable		10,000,000.0
Additional proceeds from issuance or sale of equity		20,000,000.0
Original issue discounts on debt instrument issuance		300,000
Increase in original issue discounts on debt instrument issuance, subject to contingencies		$ 500,000
Maximum
Debt Instrument [Line Items]
Promissory notes interest rate		15.00%
Scenario Forecast
Debt Instrument [Line Items]
Minimum liquidity balance required	$ 3,000,000.0
Scenario Forecast | Promissory Note One
Debt Instrument [Line Items]
Promissory Note, up on redemption					$ 1,400,000
Scenario Forecast | Promissory Note Two
Debt Instrument [Line Items]
Promissory Note, up on redemption					$ 1,000,000.0
Scenario Forecast | Promissory Notes
Debt Instrument [Line Items]
Rate of exit fee on redemption amount					6.00%
Scenario Forecast | Minimum | Securities Purchase Agreement
Debt Instrument [Line Items]
Gross proceeds from sale of common shares												$ 5,600,000
Aggregate market value of common stock and any other equity securities held by persons												75,000,000.0
Proceeds from issuance or sale of equity net												$ 25,600,000
2021 Term Loan
Debt Instrument [Line Items]
Notes/Loan payable			10,000,000	$ 30,000,000			7,000,000	7,000,000		$ 7,000,000
Debt instrument frequency of periodic payment				monthly
Revenue milestone										$ 65,000,000
Debt instrument description										The 2021 Term Loan provides for an “interest-only” period from the Effective Date through February 28, 2023, with interest due and payable monthly on the first calendar day of each month. However, the Company achieved a revenue milestone of at least $65 million on a trailing twelve-month basis during the three months ended March 31, 2021 which automatically extended the interest-only period through February 28, 2024. Beginning on the first calendar day of the month following the end of the interest-only period, the 2021 Term Loan shall be payable in (i) consecutive equal installments of principal through March 1, 2026, plus (ii) monthly payments of accrued interest. The principal amount outstanding under the 2021 Term Loan shall accrue interest at a floating per annum rate equal to the greater of (i) 2.00% above the prime rate, or (ii) 5.25%, which interest, in each case, shall be payable monthly. Changes to the interest rate applicable to the 2021 Term Loan based on changes to the prime rate shall be effective on the effective date of any change to the prime rate.
Repayments of debt										$ 2,700,000
Debt instrument, covenant description										The 2021 Term Loan requires the Company to comply with a minimum liquidity ratio covenant (as defined) by the 2021 Term Loan of not less than 0.95 to 1.00, and had a trailing six month rolling minimum revenue requirement of not less than 70% of the Company’s projected revenue performed at the end of each reporting period.
2021 Term Loan | Prior to First Anniversary
Debt Instrument [Line Items]
Debt instrument, prepayment penalty				3.00%
2021 Term Loan | Prior to Second Anniversary
Debt Instrument [Line Items]
Debt instrument, prepayment penalty				2.00%
2021 Term Loan | After Second Anniversary, Prior to October 19, 2025
Debt Instrument [Line Items]
Debt instrument, prepayment penalty				1.00%
2021 Term Loan | Thereafter
Debt Instrument [Line Items]
Debt instrument, prepayment penalty				0.00%
2021 Term Loan | Maximum
Debt Instrument [Line Items]
Minimum liquidity ratio covenant				0.95
Percentage of minimum revenue requirement				70.00%						75.00%
2021 Term Loan Amendment
Debt Instrument [Line Items]
Restricted cash collateral account							15,000,000	15,000,000		$ 15,000,000
2021 Term Loan Amendment | Maximum
Debt Instrument [Line Items]
Cash and cash equivalents							$ 40,000,000	$ 40,000,000		40,000,000
Second Amendment
Debt Instrument [Line Items]
Repayments of debt			20,000,000							20,000,000
Milestone payment			4,600,000
Prepayment fee waived amount			$ 600,000
Partial repayments of debt										$ 20,000,000
Third Amendment to 2021 Term Loan
Debt Instrument [Line Items]
Repayments of debt						3,000,000.0
Third Amendment to 2021 Term Loan | To be paid on September 30, 2022
Debt Instrument [Line Items]
Repayments of debt						$ 2,000,000.0